The world's oldest annual marathon gets under way this weekend. It's a big event for the runners, but it's also a huge one for the city of Boston and numerous companies.
Keep Reading →
April 13 - News
The process of developing a drug from start to finish is incredibly arduous, usually involves around $1 billion in costs, and can take upwards of a decade to complete.
Keep Reading →
April 12 - News
The Dow Jones Industrial Average (INDEXDJX:.DJI) has been on a tear this year.
Keep Reading →
April 12 - News
While the Dow Jones Industrial Average (INDEXDJX:.DJI) continues to climb to new heights on little more than a central bank-induced asset levitation scheme and closing the day...
Keep Reading →
April 12 - News
Merck & Co., Inc. (NYSE:MRK) stock soared almost 3% Wednesday to close in on a new 52-week high after the pharmaceutical giant announced the FDA accepted its new drug application...
Keep Reading →
April 12 - News
Thanks to a few top stocks, the Dow Jones Industrial Average managed to once again set a new all-time closing high at 14,865.
Keep Reading →
April 11 - News
I had recommended staying away from the company for now because it looked too risky with a long wait before the company could complete its second phase 3 trial for pimavanserin...
Keep Reading →
April 11 - News
There are several factors that could hurt other stocks that shouldn't be an issue for Johnson & Johnson (NYSE:JNJ). For example.
Keep Reading →
April 11 - News
The Dow Jones Industrial Average jumped again today, riding a wave that carried the S&P 500 up 1.2% and lifted the Nasdaq 1.8%.
Keep Reading →
April 11 - News
Investors have been as clear as they can be about what they see as their ideal situation.
Keep Reading →
April 10 - News
The Dow Jones Industrial Average isn't just for industrial stocks anymore.
Keep Reading →
April 10 - News
As I noted six weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
April 10 - News
Investors love stocks that consistently beat the Street without getting ahead of their fundamentals and risking a meltdown.
Keep Reading →
April 9 - News
We track 13F filings from hedge funds and other notable investors in our database, aiding us in our work developing investing strategies (we have found, for example, that the ...
Keep Reading →
April 8 - Hedge Funds
Johnson & Johnson (NYSE:JNJ) was in 67 hedge funds' portfolio at the end of December. JNJ has experienced a decrease in hedge fund interest in recent months.
Keep Reading →
April 8 - News
Is the prestige really worth a place on the Dow Jones Industrial Average (Dow Jones Indices:.DJI)? Let's ask Pfizer Inc. (NYSE:PFE), Verizon Communications Inc.
Keep Reading →
April 8 - News
April showers might bring May flowers, but the first week of the new month has already seen several health-care stocks hit full bloom.
Keep Reading →
April 7 - News
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Keep Reading →
April 7 - News
Benjamin Graham’s oldest student, who is still alive, is 106-year-old Irving Kahn.
Keep Reading →
April 7 - Hedge Funds
Abbott Laboratories (NYSE:ABT) has begun its new future swimmingly.
Keep Reading →
April 5 - News
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
April 5 - News
Making money in business typically happens in one of two ways. You either sell a relatively low-cost product to a large number of customers.
Keep Reading →
April 4 - News
The Dow Jones Industrial Average 2 Minute rose higher by 89 points, or 0.61%, today, after positive factory orders data and a higher-than-expected Medicare reimbursement rate ...
Keep Reading →
April 3 - News
The index has hit a new intraday record high in its latest surge, and as of 2:15 p.m. EDT the Dow has advanced 95 points, or 0.6%.
Keep Reading →
April 2 - News
Dublin-based pharmaceutical and medical device company Covidien plc (NYSE:COV) recently announced that it had authorized a share buyback program that could be worth up to $2...
Keep Reading →
April 2 - News
The Dow Jones Industrial Average 2 Minute jumped this morning following a slight decline yesterday.
Keep Reading →
April 2 - News
It's been quite a while since we had a big wedding in the pharma world.
Keep Reading →
March 28 - News
After a wildly successful IPO that raised over $2 billion, and valued the newly-created company at more than $12 billion, pharmaceutical giant Pfizer Inc.
Keep Reading →
March 28 - News
There has been a significant rally in the share price of Celldex Therapeutics, Inc. (NASDAQ:CLDX) recently.
Keep Reading →
March 27 - News
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Keep Reading →
March 26 - News
Pfizer Inc. (NYSE:PFE) is the largest healthcare company in the world in terms of market capitalization.
Keep Reading →
March 26 - News
The biotech sector can occasionally throw a curveball at investors. For Trius Therapeutics, Inc.
Keep Reading →
March 26 - News
Will good news from Europe echo on this side of the Atlantic within the next few days? Biogen Idec Inc. (NASDAQ:BIIB) is certainly hoping so.
Keep Reading →
March 25 - News
The Dow Jones Industrial Average rose by 90 points on Friday -- the exact amount it fell the day before -- on hopes that a deal between the European Union and Cyprus would get...
Keep Reading →
March 25 - News
What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Keep Reading →
March 25 - News
Big pharma loves Obamacare, right? After all, the main lobbying group for big pharma, the Pharmaceutical Researchers and Manufacturers of America, or PhRMA, spent $150 million...
Keep Reading →
March 23 - News
ACADIA Pharmaceuticals Inc.
Keep Reading →
March 22 - News
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Keep Reading →
March 22 - News
It’s almost here! Johnson & Johnson (NYSE:JNJ) is eagerly awaiting a decision on its type 2 diabetes drug Invokana (canagliflozin) by the end of the month.
Keep Reading →
March 22 - News
Sometimes, as investors, we can lose sight of the bigger picture. We can get caught up in the latest fad and complex indicators, hoping to get an edge.
Keep Reading →
March 21 - News
In order to be in the top fifty companies with available cash, a company would have to have $4.9 billion in cash -- 69% higher than in 2006.
Keep Reading →
March 21 - News
Six to seven weeks after the end of each quarter, hedge funds and other major investors file 13Fs with the SEC to disclose many of their long equity positions as of the end of...
Keep Reading →
March 21 - Hedge Funds
The demand for drugs worldwide is expected to increase due to emerging markets abroad and more specifically, due to an influx of demand from the aging "Baby Boomers" domestically...
Keep Reading →
March 20 - News
As I noted three weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
March 20 - News
There were cheers for joy when Abbott Laboratories (NYSE:ABT) announced that it would split itself into two entities -- separating the device and diagnostics businesses from ...
Keep Reading →
March 19 - News
Despite my recent obsession with Johnson & Johnson (NYSE:JNJ)'s restoration to health, I've long been a closet admirer of rival Pfizer Inc. (NYSE:PFE).
Keep Reading →
March 19 - News
One thing that many investors become fixated on is always wanting the next 'hot tip' or the 'inside word.' Forever seeking an edge on everyone else, investors seek the holy grail...
Keep Reading →
March 18 - News
Shares of Johnson & Johnson (NYSE:JNJ) have climbed 16% over the past five months and as of this writing, the stock is making new 52-week highs.
Keep Reading →
March 18 - News
With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed-income positions and into stocks to find yield.
Keep Reading →
March 18 - Dividend Stocks
